Published in Cancer Weekly, December 11th, 2007
"We show here that one of the miRs predicted by the data base, miR145, whether transfected as a synthetic oligonucleotide or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.